<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="tbl1" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 1
       </label>
<caption id="cap0010">
<simple-para id="tspara0010" view="all">
         Current WHO international standards (IS) for coagulation FVIII and FIX.
        </simple-para>
</caption>

<tgroup cols="5">
<colspec colname="col1" colnum="1"/>
<colspec colname="col2" colnum="2"/>
<colspec colname="col3" colnum="3"/>
<colspec colname="col4" colnum="4"/>
<colspec colname="col5" colnum="5"/>
<thead>
<tr trsep="1" valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Standard
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           NIBSC Code
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Assigned potency
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Purpose
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Year established
          </td>
</tr>
</thead>
<tbody>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           8th IS for FVIII concentrate
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           07/350
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           9.4 IU per ampoule
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           To calibrate secondary and/or in-house working Factor VIII concentrate standards
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2010
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           6th IS for FVIII and von Willebrand Factor, plasma
           
</td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           07/316
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.68 IU per ampoule
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           For the estimation of FVIII activity in human plasma
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2008
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           5th IS for FIX concentrate
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           14/148
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           10.5 IU per ampoule
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           For the calibration of factor IX functional activity in therapeutic concentrates
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2015
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           4th IS for Blood Coagulation Factors II, VII, IX, X, plasma
           
</td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           09/172
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.86 IU per ampoule
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           For use as a primary reference standard for calibration of factors II, VII, IX and X functional activity in plasma sample
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2010
          </td>
</tr>
</tbody>
</tgroup>
<table-footnote id="tbl1fna">

<note-para id="ntpara0010" view="all">
         In addition to FVIII activity, this IS has the following values assigned: FVIII Antigen (FVIII:Ag), von Willebrand Factor Antigen (VWF:Ag), von Willebrand Factor Ristocetin Cofactor function (VWF:RCo), VWF binding to recGPIb - ristocetin-dependent (VWF:GPIbR), VWF binding to recGPIb - gain-of-function mutant (VWF:GPIbM), von Willebrand Factor Collagen Binding function (VWF:CB), and von Willebrand Factor Propeptide (VWFpp).
        </note-para>
</table-footnote>
<table-footnote id="tbl1fnb">

<note-para id="ntpara0015" view="all">
         This IS has also been assigned a FIX antigen value.
        </note-para>
</table-footnote>
</table>
</html>
<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="tbl3" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 3
       </label>
<caption id="cap0020">
<simple-para id="tspara0020" view="all">
         Invited stakeholders who presented position statements at the meeting.
        </simple-para>
</caption>

<tgroup cols="2">
<colspec colname="col1" colnum="1"/>
<colspec colname="col2" colnum="2"/>
<thead>
<tr trsep="1" valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Organization type
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Participants
          </td>
</tr>
</thead>
<tbody>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Regulatory agencies and standard setting agencies
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Paul-Ehrlich-Institut (PEI, Germany), U.S. Food and Drug Administration, Center for Biologics Evaluation and Research (U.S. FDA/CBER, USA), National Institute for Biological Standards and Control (NIBSC, UK), Health Canada (Canada), Therapeutic Goods Administration (TGA, Australia), National Institute of Biologicals (NOIDA, India), European Directorate for the Quality of Medicines (EDQM), United States Pharmacopoeia (USP)
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Patient and professional organizations
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           World Federation of Haemophilia (WFH), UK Haemophilia Doctors' Organisation (UKHDO) and The International Society on Thrombosis and Haemostasis (ISTH)
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Industry
           <br/>
           Industry organizations
           <br/>
           FVIII and FIX Manufacturers
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           International Plasma Fractionation Association (IPFA) and Plasma Protein Therapeutics Association (PPTA)
           <br/>
           CSL Behring, Novo Nordisk, Octapharma, Sanofi, Takeda, Shandong and Genentech
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           IVD manufacturers
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Rossix, Stago, Technoclone, Werfen, Enzyre
          </td>
</tr>
<tr valign="top">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Clinical laboratories
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           External quality Control of diagnostic Assays and Tests (ECAT), External Quality Assurance in Thrombosis and Hemostasis (EQATH), North American Specialized Coagulation Laboratory Association (NASCOLA), UK National External Quality Assurance Scheme (UK NEQAS)
          </td>
</tr>
</tbody>
</tgroup>
</table>
</html>
